Recursion Pharmaceuticals Inc (RXRX)
7.62
+0.27
(+3.67%)
USD |
NASDAQ |
Apr 22, 16:00
7.63
+0.01
(+0.13%)
After-Hours: 04:44
Recursion Pharmaceuticals Price to Book Value: 3.858 for April 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 3.858 |
| April 19, 2024 | 3.722 |
| April 18, 2024 | 3.747 |
| April 17, 2024 | 3.782 |
| April 16, 2024 | 3.833 |
| April 15, 2024 | 3.944 |
| April 12, 2024 | 4.258 |
| April 11, 2024 | 4.516 |
| April 10, 2024 | 4.344 |
| April 09, 2024 | 4.603 |
| April 08, 2024 | 4.557 |
| April 05, 2024 | 4.491 |
| April 04, 2024 | 4.420 |
| April 03, 2024 | 4.522 |
| April 02, 2024 | 4.440 |
| April 01, 2024 | 4.744 |
| March 28, 2024 | 5.048 |
| March 27, 2024 | 5.149 |
| March 26, 2024 | 5.225 |
| March 25, 2024 | 5.332 |
| March 22, 2024 | 5.311 |
| March 21, 2024 | 5.392 |
| March 20, 2024 | 5.605 |
| March 19, 2024 | 5.443 |
| March 18, 2024 | 5.782 |
| Date | Value |
|---|---|
| March 15, 2024 | 5.681 |
| March 14, 2024 | 5.458 |
| March 13, 2024 | 5.560 |
| March 12, 2024 | 5.337 |
| March 11, 2024 | 5.251 |
| March 08, 2024 | 5.666 |
| March 07, 2024 | 5.646 |
| March 06, 2024 | 5.732 |
| March 05, 2024 | 6.030 |
| March 04, 2024 | 6.228 |
| March 01, 2024 | 6.486 |
| February 29, 2024 | 6.815 |
| February 28, 2024 | 6.552 |
| February 27, 2024 | 7.858 |
| February 26, 2024 | 7.474 |
| February 23, 2024 | 6.770 |
| February 22, 2024 | 7.595 |
| February 21, 2024 | 6.263 |
| February 20, 2024 | 6.375 |
| February 16, 2024 | 6.658 |
| February 15, 2024 | 6.294 |
| February 14, 2024 | 5.529 |
| February 13, 2024 | 4.960 |
| February 12, 2024 | 5.539 |
| February 09, 2024 | 5.109 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.756
Minimum
May 11 2022
10.83
Maximum
Jul 13 2021
4.283
Average
3.944
Median
Apr 15 2024
Price to Book Value Benchmarks
| Eli Lilly and Co | 64.55 |
| Palatin Technologies Inc | -- |
| Oragenics Inc | 3.015 |
| Editas Medicine Inc | 1.315 |
| BioXcel Therapeutics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 36.02 |
| PEG Ratio | -0.3325 |
| Price | 7.62 |
| Earnings Yield | -20.60% |
| Market Cap | 1.788B |
| PEGY Ratio | -0.3325 |